Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study status was updated to Active, not recruiting on 2026-01-07. A new page revision (v3.3.4) was posted on 2026-01-07, replacing the previous v3.3.3 revision.
    Difference
    0.2%
    Check dated 2026-01-14T03:51:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Expanded recruitment sites across the US, Australia, and Europe and updated contact details; added new locations and investigators while removing some prior sites.
    Difference
    3%
    Check dated 2025-12-23T20:30:49.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Updated the study record with December 2025 update timestamps and removed October 2025 timestamps, reflecting routine record maintenance rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T14:22:30.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Publications section wording was updated to reflect that publications are automatically filled from PubMed, replacing the previous description, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-24T20:53:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Removed the government funding status notice banner, which previously informed users that information may not be up to date and NIH operations could be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T18:15:47.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Deleted the previous ALLELE trial entry for EBV+ PTLD and added a new Phase 3 ALLELE entry with updated study procedures, an enrollment target of 115, expanded locations, and new contact details (Claire Fabre).
    Difference
    3%
    Check dated 2025-11-03T12:54:03.000Z thumbnail image

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.